Erasca rallied by 8.94 percent on Tuesday to close at $19.50 apiece, as investor sentiment was boosted by the strong clinical ...

Celcuity received approval from the Food and Drug Administration for Revtorpyk, its breast cancer treatment. The agency approved the drug, known generically as gedatolisib, to treat patients with ...

An Alzheimer’s drug could prevent dementia before symptoms show, with research suggesting it could clear toxic brain plaques ...

E-cigarettes are viewed by many, including the FDA, as a harm reduction for smokers. But with 86 percent of U.S. products ...

Sound Pharmaceuticals is pleased to announce that it completed enrollment of its second Phase 3 open label study of SPI-1005 for the Treatment of Meniere’s Disease (MD). SPI-1005, a novel oral ...

The FDA's acceptance of the NDA for AD109 marks a pivotal clinical milestone toward introducing the first oral pharmacotherapy designed to target the neuromuscular causes of obstructive sleep apnea.

The U.S. Food and Drug Administration is speeding up its review of an oral medicine for sickle cell disease that may fill a ...

Whatever reservations Jacob Ramirez might have had about his “therapy” session last year using the hallucinogen psilocybin ...

Biomarker discovery has played an essential role in the development of more effective therapy for multiple types of solid ...

Would you want two strangers in the room with you for hours while you're on mushrooms? The federal government just decided ...

Onion Lake Cree Nation issued an urgent drug alert following multiple overdoses and two suspected overdose-related deaths in ...

A new drug that turns cancer's own defenses against itself has shown "promise" in treating one of the deadliest forms of the ...